UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 29, 2003
PROTEIN DESIGN LABS, INC.
|
|
|
|
|
|
34801 Campus Drive
Fremont, California 94555
(510) 574-1400
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Item 7. Financial Statements and Exhibits.
(c) Exhibits.
99.1 Press Release dated April 29, 2003.
Item 9. Regulation FD Disclosure
On April 29, 2003, Protein Design Labs, Inc. ("PDL") announced its financial results for the quarter ended March 31, 2003. A copy of PDL's press release is attached hereto as Exhibit 99.1.
In accordance with SEC Release No. 33-8216, the information in this Form 8-K and the exhibit attached hereto are being furnished under Item 9 rather than under Item 12.
Use of Non-GAAP Financial Information
To supplement the information that is presented in accordance with generally
accepted accounting principles in the United States ("GAAP"), in its forward-looking guidance PDL
uses non-GAAP measures of costs and expenses and net loss that exclude a certain acquisition-related
charge for acquired in-process research and development. We believe that non-GAAP measures enhance
an investor's overall understanding of our financial performance and future prospects by excluding
expenses that in management's view are unrelated to our core operations and whose inclusion may make
it more difficult for investors to compare our results from period to period.
SIGNATURES
Pursuant to the requirement of the Security Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: April 29, 2003
PROTEIN DESIGN LABS, INC. |
By: | /s/ Sergio Garcia-Rodriguez |
| |
Sergio Garcia-Rodriguez | |
Vice President, Legal and General Counsel |
INDEX TO EXHIBITS
|
Description |
|
* Also provided in PDF format as a courtesy.